Understanding how GLP-1 medicines help with asthma in people who are lean or have obesity
GLP-1R agonist immune targets in lean and obesity-associated asthma
This project aims to discover how existing GLP-1 medicines, used for diabetes and obesity, can also help reduce inflammation in people with asthma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11171513 on NIH RePORTER |
What this research studies
We know that certain medicines called GLP-1R agonists, already approved for conditions like type 2 diabetes and obesity, show promise for treating asthma. However, we don't fully understand how these medicines work to calm airway inflammation. This project seeks to identify the specific immune cells and processes that GLP-1R agonists affect in asthma. By understanding these mechanisms, we hope to improve how these medicines can be used to help both lean and obese patients manage their asthma.
Who could benefit from this research
Good fit: This foundational research focuses on understanding disease mechanisms and may eventually benefit patients with asthma, regardless of whether they are lean or have obesity.
Not a fit: Patients who do not have asthma or conditions related to GLP-1R agonist use would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new and more effective ways to use existing GLP-1R agonist medications to treat asthma, potentially offering better relief from inflammation.
How similar studies have performed: Preclinical and clinical studies have already shown that GLP-1R agonists are a promising new treatment approach for asthma, though the exact mechanisms are still being explored.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Cahill, Katherine N — Vanderbilt University Medical Center
- Study coordinator: Cahill, Katherine N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.